JP2021167320A5 - - Google Patents

Download PDF

Info

Publication number
JP2021167320A5
JP2021167320A5 JP2021101469A JP2021101469A JP2021167320A5 JP 2021167320 A5 JP2021167320 A5 JP 2021167320A5 JP 2021101469 A JP2021101469 A JP 2021101469A JP 2021101469 A JP2021101469 A JP 2021101469A JP 2021167320 A5 JP2021167320 A5 JP 2021167320A5
Authority
JP
Japan
Prior art keywords
amino
cancer
pyridin
group
pyrazol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021101469A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021167320A (ja
Filing date
Publication date
Priority claimed from JP2021503933A external-priority patent/JPWO2021205631A1/ja
Priority claimed from JP2021066254A external-priority patent/JP6912016B1/ja
Application filed filed Critical
Publication of JP2021167320A publication Critical patent/JP2021167320A/ja
Publication of JP2021167320A5 publication Critical patent/JP2021167320A5/ja
Pending legal-status Critical Current

Links

JP2021101469A 2020-04-10 2021-06-18 Sting作動化合物 Pending JP2021167320A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2021503933 2020-04-10
JP2021503933A JPWO2021205631A1 (cg-RX-API-DMAC10.html) 2020-04-10 2020-04-10
JP2021066254A JP6912016B1 (ja) 2020-04-10 2021-04-09 Sting作動化合物

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2021066254A Division JP6912016B1 (ja) 2020-04-10 2021-04-09 Sting作動化合物

Publications (2)

Publication Number Publication Date
JP2021167320A JP2021167320A (ja) 2021-10-21
JP2021167320A5 true JP2021167320A5 (cg-RX-API-DMAC10.html) 2024-03-28

Family

ID=76969224

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021066254A Active JP6912016B1 (ja) 2020-04-10 2021-04-09 Sting作動化合物
JP2021101469A Pending JP2021167320A (ja) 2020-04-10 2021-06-18 Sting作動化合物

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2021066254A Active JP6912016B1 (ja) 2020-04-10 2021-04-09 Sting作動化合物

Country Status (1)

Country Link
JP (2) JP6912016B1 (cg-RX-API-DMAC10.html)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002069061A (ja) * 2000-08-30 2002-03-08 Canon Inc オキサゾール化合物及びそれを用いた有機発光素子
ATE554087T1 (de) * 2004-10-29 2012-05-15 Abbott Lab Neue kinaseinhibitoren
WO2015160636A1 (en) * 2014-04-16 2015-10-22 Merck Sharp & Dohme Corp. Factor ixa inhibitors
WO2016024233A1 (en) * 2014-08-13 2016-02-18 Auckland Uniservices Limited Inhibitors of tryptophan dioxygenases (ido1 and tdo) and their use in therapy
JP6411676B2 (ja) * 2015-12-03 2018-10-24 グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドGlaxosmithkline Intellectual Property Development Limited Stingの調節因子としての環状プリンジヌクレオチド
CN112105357A (zh) * 2018-02-16 2020-12-18 Ucb生物制药有限责任公司 药用6,5杂双环衍生物
TWI873098B (zh) * 2018-07-03 2025-02-21 瑞士商諾華製藥公司 用於治療與sting活性相關之病症的化合物及組合物

Similar Documents

Publication Publication Date Title
TWI869913B (zh) 吡啶并[4,3-d]嘧啶化合物
ES3036496T3 (en) Fused tricyclic ring derivatives as src homology-2 phosphatase inhibitors
ES2819448T3 (es) Tetrahidro-pirido[3,4-b]indoles como moduladores del receptor de estrógenos y usos de los mismos
CA3219236A1 (en) Exatecan derivatives and antibody-drug conjugates thereof
CN103748099B (zh) 作为蛋白激酶抑制剂的大环化合物
KR20210075992A (ko) Sting 작동 화합물
AU2016366680B2 (en) Benzothiophene-based selective estrogen receptor downregulators
EP2890698B1 (en) Dioxino- and oxazin-[2,3-d]pyrimidine pi3k inhibitor compounds and methods of use
RU2017145026A (ru) Соединение, ингибирующее brk
KR20250100539A (ko) 피리도[4,3-d]피리미딘 화합물
BR112012006807A2 (pt) compostos da fórmula i, composição farmacêutica, composta por composto, método de tratamento de câncer em um mamífero, uso de um composto, kit para tratar um condição mediada por pi3k e processo para a preparação de um composto
RU2012131082A (ru) Аминопиримидиновые ингибиторы киназ
JP2017533223A (ja) ユビキチン活性化酵素阻害物質及び化学療法剤の投与
SG171765A1 (en) Pyrazolopyridine pi3k inhibitor compounds and methods of use
CN104513258B (zh) 取代脲衍生物及其在药物中的应用
JP7479292B2 (ja) 組み合わせ医薬として用いられるezh1/2二重阻害剤を含有する医薬組成物
WO2011094260A2 (en) Novel bifunctional metnase/intnase inhibitors and related compositions and methods of treatment of cancer
JPWO2021206158A5 (cg-RX-API-DMAC10.html)
CN114786674A (zh) Ahr抑制剂和pd1抑制剂抗体的组合及其在癌症治疗中的用途
KR20220167275A (ko) 암 치료 방법
JP2008545803A5 (cg-RX-API-DMAC10.html)
NZ774859B2 (en) Sting agonistic compound
WO2022169840A1 (en) Combination of dual atm and dna-pk inhibitors and immunotherapeutic agents for use in cancer therapy
HK40071759A (en) Combination of an ahr-inhibitor and an pd1-inhibitor antibody and its use in the treatment of cancer
CN105461709A (zh) 取代脲衍生物及其在药物中的应用